EUVIMEDEUVIMED entdecken
CrossrefInfokarte

MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis

Britton S. Cartee, Fabiola Diniz, Ravi P. Rai, Pabitra B. Pal, Rahul Srivastava, Daniel Rossmiller, Reben Raeman, Smita S. Iyer

Seminars in Liver Disease · 2026-06 · 46 (02) · 135-155

DOI: 10.1055/a-2908-1230 ↗
AbstractBibliografische Angaben

Abstract

“The liver is the origin of the veins and the source of the blood.”—De Usu Partium Galen. Galen's hepatocentric physiology foreshadowed the liver–brain axis, a network linking vagal signaling, cytokines, metabolites, and migratory immune cells. Central to the immune arm of this axis, the liver generates 25 to 50% of thoracic duct lymph, positioning hepatic lymphatic output as a significant, though not yet fully characterized, source of T cells and cytokines in systemic circulation, a contribution that increases with hepatic inflammation in chronic metabolic diseases. We propose that T lymphocytes are the key cellular effectors through which inflammation originating in the liver, propagating systemically, a process we term hepatosystemic inflammation, reaches the central nervous system (CNS). In metabolic dysfunction-associated steatotic liver disease, hepatosystemic inflammation generates peripheral “push signals” that may license T cells for CNS access, while neuroinflammatory “pull signals” at CNS barrier interfaces may establish permissive entry points. In conclusion, we propose that T cell licensing by hepatosystemic signals represents the immune arm of the liver–brain axis and a mechanistic bridge between metabolic liver disease and neuroimmune dysfunction and associated cognitive decline, and identifies candidate therapeutic targets along this cascade.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →